| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |